Financial, Interviews/Contributions Investor Insights: Arboretum – Stage of investment Share by Ken Dropiewski on September 24, 2026 More in Financial: AtriCure Reports Third Quarter 2026 Financial Results November 3, 2026 T45 Fund-II Secures Investment from Private Funds Advised by The O.H.I.O. Fund November 3, 2026 Thryv Therapeutics Announces $30 Million Financing to Launch the ASPIRE-HF Study in Patients with Heart Failure; Wave II Efficacy Cohort Fully Enrolled in Long QT Syndrome November 3, 2026 Share this story Facebook Twitter LinkedIn